Cambria Investment Management, L.P. Amgen Inc Transaction History

Cambria Investment Management, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $4.59 Million - $5.9 Million	-24,265 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $40,393 - $48,399	-232 Reduced 0.95%	24,265 $4.7 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $320,730 - $375,968	1,924 Added 8.52%	24,497 $4.51 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $264,070 - $297,664	1,460 Added 6.92%	22,573 $4.29 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $236,201 - $275,723	-1,324 Reduced 5.9%	21,113 $4.11 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $134,705 - $151,863	-727 Reduced 3.14%	22,437 $4.65 Million
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $352,358 - $395,774	-2,122 Reduced 8.39%	23,164 $4.43 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $1.43 Million - $1.67 Million	-8,414 Reduced 24.97%	25,286 $4.31 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $844,625 - $943,704	5,004 Added 17.44%	33,700 $5.86 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $334 - $382	2 Added 0.01%	28,696 $5.35 Million
Q2 2017 Aug 14, 2017	BUY	N/A	28,694	28,694 $4.94 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cambria Investment Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Cambria Investment Management, L.P. with notifications on news.